Current and Long-Term Liabilities (Tables)

12 Months Ended

Dec. 31, 2014

Current and Long-Term Liabilities

Schedule of accrued expenses

Accrued expenses consisted of the following as of December 31, 2014 and 2013 (in thousands):

	December 31,
	2014		2013
Commercial rebates, fees and returns	$	44,807	$	4,839
Professional, license, and other fees and expenses		14,888		1,932
Salaries, bonuses, and other compensation		10,176		5,419
Clinical, manufacturing and regulatory consulting fees and expenses		7,181		7,834
Restructuring expense		1,952		—
Commercial consulting fees and expenses		1,089		1,301
Short-term contingent consideration		718		941
Total accrued expenses	$	80,811	$	22,266

Schedule of deferred revenues

Deferred revenues consisted of the following as of December 31, 2014 and 2013 (in thousands):

	December 31,
	2014		2013
Short-term deferred revenues:
Takeda	$	44,376	$	8,226
Total	$	44,376	$	8,226
Long-term deferred revenues:
Takeda	$	—	$	43,534
3SBio		—		1,000
Total	$	—	$	44,534